178 related articles for article (PubMed ID: 10323196)
1. Conformational analyses of cyclic hexapeptide analogs of somatostatin containing arylalkyl peptoid and naphthylalanine residues.
Mattern RH; Tran TA; Goodman M
J Pept Sci; 1999 Apr; 5(4):161-75. PubMed ID: 10323196
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and binding properties of cyclohexapeptide somatostatin analogs containing naphthylalanine and arylalkyl peptoid residues.
Tran TA; Mattern RH; Morgan BA; Taylor JE; Goodman M
J Pept Sci; 1999 Mar; 5(3):113-30. PubMed ID: 10323556
[TBL] [Abstract][Full Text] [Related]
3. Conformational analyses by 1H NMR and computer simulations of cyclic hexapeptides related to somatostatin containing acidic and basic peptoid residues.
Mattern RH; Tran TA; Goodman M
J Pept Res; 1999 Feb; 53(2):146-60. PubMed ID: 10195452
[TBL] [Abstract][Full Text] [Related]
4. Conformational analyses of somatostatin-related cyclic hexapeptides containing peptoid residues.
Mattern RH; Tran TA; Goodman M
J Med Chem; 1998 Jul; 41(15):2686-92. PubMed ID: 9667959
[TBL] [Abstract][Full Text] [Related]
5. Conformational analyses of sandostatin analogs containing stereochemical changes in positions 6 or 8.
Mattern RH; Zhang L; Rueter JK; Goodman M
Biopolymers; 2000 May; 53(6):506-22. PubMed ID: 10775066
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biologic activity of conformationally constrained analogs of L-363,301.
Moore SB; Grant M; Rew Y; Bosa E; Fabbri M; Kumar U; Goodman M
J Pept Res; 2005 Dec; 66(6):404-22. PubMed ID: 16316457
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological activities of potent and selective somatostatin analogues incorporating novel peptoid residues.
Tran TA; Mattern RH; Afargan M; Amitay O; Ziv O; Morgan BA; Taylor JE; Hoyer D; Goodman M
J Med Chem; 1998 Jul; 41(15):2679-85. PubMed ID: 9667958
[TBL] [Abstract][Full Text] [Related]
8. A bioactive somatostatin analog without a type II' beta-turn: synthesis and conformational analysis in solution.
Jiang S; Gazal S; Gelerman G; Ziv O; Karpov O; Litman P; Bracha M; Afargan M; Gilon C; Goodman M
J Pept Sci; 2001 Oct; 7(10):521-8. PubMed ID: 11695647
[TBL] [Abstract][Full Text] [Related]
9. Absolute configuration for peptidomimetic residues in bioactive peptides.
Yamazaki T; Goodman M
Chirality; 1991; 3(4):268-76. PubMed ID: 1742164
[TBL] [Abstract][Full Text] [Related]
10. Conformational mimicry: synthesis and solution conformation of a cyclic somatostatin hexapeptide containing a tetrazole cis amide bond surrogate.
Beusen DD; Zabrocki J; Slomczynska U; Head RD; Kao JL; Marshall GR
Biopolymers; 1995 Aug; 36(2):181-200. PubMed ID: 7492745
[TBL] [Abstract][Full Text] [Related]
11. Cyclic hexapeptide analogs of somatostatin containing bridge modifications. Syntheses and conformational analyses.
Huang Z; Pröbstl A; Spencer JR; Yamazaki T; Goodman M
Int J Pept Protein Res; 1993 Oct; 42(4):352-65. PubMed ID: 7902342
[TBL] [Abstract][Full Text] [Related]
12. Development of specific and non-specific somatostatin analogs.
Nakano T; Harano Y; Emura J; Kimura T; Sakakibara S; Shigeta Y
Horm Metab Res; 1986 Feb; 18(2):98-102. PubMed ID: 2870971
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and binding potencies of cyclic hexapeptide analogs of somatostatin incorporating acidic and basic peptoid residues.
Tran TA; Mattern RH; Morgan BA; Taylor JE; Goodman M
J Pept Res; 1999 Feb; 53(2):134-45. PubMed ID: 10195451
[TBL] [Abstract][Full Text] [Related]
14. Thermodynamic origin of cis/trans isomers of a proline-containing beta-turn model dipeptide in aqueous solution: a combined variable temperature 1H-NMR, two-dimensional 1H,1H gradient enhanced nuclear Overhauser effect spectroscopy (NOESY), one-dimensional steady-state intermolecular 13C,1H NOE, and molecular dynamics study.
Troganis A; Gerothanassis IP; Athanassiou Z; Mavromoustakos T; Hawkes GE; Sakarellos C
Biopolymers; 2000 Jan; 53(1):72-83. PubMed ID: 10644952
[TBL] [Abstract][Full Text] [Related]
15. Cyclic hexapeptides related to somatostatin. Synthesis and biological testing.
Pattaroni C; Lucietto P; Goodman M; Yamamoto G; Vale W; Moroder L; Gazerro L; Göhring W; Schmied B; Wünsch E
Int J Pept Protein Res; 1990 Nov; 36(5):401-17. PubMed ID: 1980489
[TBL] [Abstract][Full Text] [Related]
16. The conformational properties of somatostatin. IV. The conformers contributing to the conformation equilibrium of somatostatin in aqueous solution as found by semi-empirical energy calculations and high-resolution NMR experiments.
Knappenberg M; Michel A; Scarso A; Brison J; Zanen J; Hallenga K; Deschrijver P; van Binst G
Biochim Biophys Acta; 1982 Jan; 700(2):229-46. PubMed ID: 6120006
[TBL] [Abstract][Full Text] [Related]
17. Impact of cis-proline analogs on peptide conformation.
Che Y; Marshall GR
Biopolymers; 2006 Apr; 81(5):392-406. PubMed ID: 16358327
[TBL] [Abstract][Full Text] [Related]
18. Examination of structural characteristics of the potent oxytocin antagonists [dPen1,Pen6]-OT and [dPen1,Pen6, 5-tBuPro7]-OT by NMR, Raman, CD spectroscopy and molecular modeling.
Bélec L; Blankenship JW; Lubell WD
J Pept Sci; 2005 Jul; 11(7):365-78. PubMed ID: 15641022
[TBL] [Abstract][Full Text] [Related]
19. Topochemical design of bioactive peptides and peptidomimetics.
Goodman M; Ro S; Yamazaki T; Spencer JR; Toy A; Huang Z; He Y; Reisine T
Bioorg Khim; 1992; 18(10-11):1375-93. PubMed ID: 1363715
[TBL] [Abstract][Full Text] [Related]
20. Novel sst(4)-selective somatostatin (SRIF) agonists. 4. Three-dimensional consensus structure by NMR.
Grace CR; Koerber SC; Erchegyi J; Reubi JC; Rivier J; Riek R
J Med Chem; 2003 Dec; 46(26):5606-18. PubMed ID: 14667215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
